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Anton Bruil, Tom Beugeling, Jan Feijen, and Willem G. van Aken 
C ONVINCING evidence exists that blood transfusions are associated with deleterious 
effects caused by residual leukocytes in blood and 
blood components. These side effects include al- 
loimmunization to histocompatibility antigens, 
transmission of viruses, immunosuppression a d 
graft-versus-host disease (GVHD). Leukocyte de- 
pletion of blood components may prevent or ame- 
liorate some of these harmful effects. Among the 
various methods to remove or reduce leukocytes in 
blood components, filters have been shown to be 
most efficient. However, the mechanism of leuko- 
cyte depletion by such filters is not completely 
understood, which limits the development of im- 
proved, cost-effective, and clinically applicable 
filter materials. 
The aim of this review article is to discuss the 
development of leukocyte filters, the various 
mechanisms of leukocyte filtration, and mathemat- 
ical models to describe the process of leukocyte 
filtration. 
CLINICAL APPLICATION OF 
LEU KOCYTE-DEPLETED 
BLOOD COMPONENTS 
The prophylactic use of red blood cell transfu- 
sions containing fewer than 5 x 10 6 leukocytes per 
transfused unit has been shown to prevent or delay 
the acquisition of nonhemolytic febrile transfusion 
reactions (NHFTR) in patients who are transfusion 
dependent.~-3 Leukodepletion is also an effective 
method to abolish recurrent NHFTR to red blood 
cell concentrates. NHFTR are preceded by the for- 
mation of antibodies directed against HLA anti- 
gens on donor cells. HLA immunization may also 
be the cause of refractoriness to random donor 
platelet ransfusions. 4-6 However, the evidence 
that leukocyte depletion in transfused components 
can prevent the development of a refractory state is 
limited. 7 Newly diagnosed patients with severe 
aplastic anemia, who are potential recipients of 
bone marrow transplants, are candidates for leu- 
kodepleted red blood cell and platelet concen- 
trates. Once such patients become sensitized to 
HLA antigens, there is a higher isk of graft rejec- 
tion. 
Viruses that are cell-associated such as cyto- 
megalovirus (CMV), Epstein-Barr virus (EBV), 
and human T-cell lymphotropic viruses (HTLV) 
may be transmitted by blood transfusion. The re- 
moval of leukocytes from blood is effective in re- 
ducing the risk of leukocyte-associated virus trans- 
mission. 8-1~ Leukodepletion of red blood cell and 
platelet concentrates to less than 5 x 10 6 cells per 
unit has been shown to be effective in preventing 
CMV transmission. 11,12 
Although leukocyte reduction through filtration 
has been applied in a variety of other conditions, 
the evidence of clinical benefit awaits further stud- 
ies. Notably, improvements in clinical outcome, in 
terms of morbidity and mortality, have not been 
investigated a equately. The use of leukocyte-poor 
blood components has been recommended to pre- 
vent immune modulation in neonates and surgical 
patients, which might lead to a decreased rate of 
postoperative infection. 13 Similarly, cancer pa- 
tients undergoing surgery might benefit from leu- 
kodepletion of blood components because immu- 
nomodulation by transfusion is prevented and 
cancer ecurrence would be lower. The indications 
for leukodepletion of blood components are at 
present classified as only possible, until more de- 
finitive studies have been performed. 
GVHD in patients undergoing organ transplan- 
tation can be induced by transfused leukocytes. In 
theory, depletion of leukocytes could be a way to 
prevent this complication. However, gamma- 
irradiation of components has already been shown 
to be effective. TM Removal of leukocytes from 
blood may also prevent the formation of microag- 
gregates. Microaggregates are clumps of degener- 
ating leukocytes, platelets, and fibrin that are 
formed spontaneously during the storage of leuko- 
cytes containing blood. ~5 During cardiopulmonary 
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bypass surgery and massive transfusion, microag- 
gregates may induce the formation of microemboli 
in the patient's pulmonary circulation, which is 
probably associated with a large number of unex- 
plained postoperative r actions uch as acute re- 
spiratory distress yndrome (ARDS). 16-]8 The re- 
moval of microaggregates from stored blood zs and 
the removal of leukocytes from blood before stor- 
age 19'2~ may prevent hese complications. 
Techniques to Prepare Leukocyte-Poor Blood 
A variety of techniques have been developed to 
prepare leukocyte-poor blood components. 21-25 
Although many methodological variations and 
combinations of these techniques exist, five basic 
methods can be distinguished; (1) differential cen- 
trifugation, (2) sedimentation, (3) cell washing, 
(4) freezing and thawing, and (5) filtration. 
Differential centrifugation. Differential cen- 
trifugation was the earliest and is still one of the 
most frequently used techniques for the production 
of leukocyte-poor blood. 21 When blood packs are 
centrifuged, blood cells will sediment according to 
their specific size and density (Table 1). Thus, 
after centrifugation, whole blood can be separated 
into three fractions; (1) packed red blood cell con- 
centrate, (2) cell-free plasma, and (3) a leukocyte- 
and platelet-rich layer (buffy coat) that separates 
plasma from the red blood cell concentrate. By 
removal of the buffy coat approximately 70% to 
90% of the leukocytes can be depleted, with red 
blood cell loss ranging from 10% to 40%. 23,24,44,45 
However, complete separation of the various cel- 
lular components cannot be obtained by centrifu- 
gation. The depletion of leukocytes can be im- 
proved by a second centrifugation step after the 
addition of an isotonic saline solution to the packed 
red blood cells, but this procedure causes a sub- 
stantial loss of red cells. 26 
The widespread use of centrifugation for the 
preparation of leukocyte-poor blood can thus be 
attributed to its simplicity, adaptability, production 
efficiency, and ability for large-scale production. 
Shortcomings of the technique are the limited re- 
moval of leukocytes, the appreciable loss of red 
blood cells, and the relatively long processing 
time.21, 25 
Sedimentation. Spontaneous sedimentation of
red blood cells, ie, without he use of centrifuga- 
tion, can be enhanced by the addition of agents that 
promote the formation of red blood cell aggre- 
gates, known as rouleaux formation. 21 High mo- 
lecular weight dextran has been frequently used for 
this purpose. 4s-47 After sedimentation, the super- 
natant and the buffy coat can be removed, resulting 
in the depletion of more than 80% of the leuko- 
cytes. The loss of red blood cells is very low com- 
pared with other methods. Eventually, red blood 
cell concentrates can be subjected to a second sed- 
imentation procedure to improve the removal of 
residual leukocytes without significant loss of red 
blood cells. 46'47 
The advantages of dextran sedimentation are its 
low cost and the independence from special equip- 
ment. However, the technique is time consuming, 
labor intensive, and when performed in an open 
system, susceptible to the risk of bacterial contam- 
ination, thus shortening the expiration date of the 
product. This technique is no longer widely 
used. 19 
Table 1. Concentration and Physical Properties of Human Blood Cells 
Concentration* DensiWt Diameter$ 
Ceil Types (p.L 1) (g/cm 3) (i,Lrn) Deformabilityw Adhesiveness II 
Erythrocytes 4,000,000-6,000,000 1.090-1.110 7-8 eete 9 
Platelets 150,000-400,000 1.054-1.062 2-3 9 eeee 
G ran u I coytes 2,000-6,0 O0 1.080-1.084 5-8 eee eee 
Lymphocytes 1,500-4,000 1.060-1.072 4-8 ee ee 
Monocytes 200-800 1.055-1.062 4-10 ee eeee 
* Blood cell counts in adult whole blood, according to Baker and Silverton. 2s 
1" Blood cell density according to Roos and de Boer. 27 
$ Leukocyte diameters in isotonic salt solution (pH 7.4), measured by transmission electron microscopy (TEM), 2s other cell 
diameters according to Baker and Silverton. 2e 
w Relative deformability of cells (more dots, ie, more deformable), as defined by their ability to passively flow through the pores 
of a Nucleopore filter, z9-35 Deformability of platelets according to Br&nemark and LindstrSm. 3s 
tt Relative adhesiveness of cells to solid surfaces (more dots, ie, more adhesive), arbitrarily classified, and based on various reports 
in which the adhesion of specific blood cells to solid surfaces is compared. 37`43 
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Cell washing. Red blood cell washing com- 
bines differential centrifugation a d continuous di- 
lution of the cells using isotonic saline solution. 25 
A variety of automatic ell washers is currently 
available for this purpose. The centrifugation pro- 
cess in these machines i performed in a disposable 
container of defined size and geometry, which al- 
lows the various blood components obe removed 
in the order of their specific densities. However, 
the separation efficiency is limited by the small 
differences between the densities of the blood cells 
(Table 1). Depending on the process conditions, 
automatic cell washers can remove 70% to 95% of 
the leukocytes from whole blood, whereas the loss 
of red blood cells is approximately 15%. 23,24,48,49 
The major advantage of this method is its effi- 
ciency in removing more than 95% of the plasma 
from whole blood. 48'49 Plasma removal may be 
beneficial in reducing the risk of virus transmis- 
sion. 21 Disadvantages of the method are the high 
cost, the long processing time, the open-system 
handling, and the logistical problems with regard 
to the supply of cellular products. 21 Red blood cell 
washing is therefore used only occasionally for the 
routine preparation of leukocyte-poor blood. 
Freezing and thawing. The freezing method 
was developed originally for the long-term preser- 
vation of red blood cells. To protect hem against 
freezing, a cryoprotective agent, eg, glycerol, 
which is avidly taken up by red blood cells, is 
added to the blood. 5~ On freezing, ice crystals that 
rupture the cell membranes during thawing are 
formed in the leukocytes. The subsequent washing 
procedure removes both glycerol and leukocyte- 
rich stroma. 5~ With this method usually more than 
95% of the leukocytes are removed, whereas red 
blood cell loss is less than 10%. 22-24,52 However, 
it should be noted that red blood cell concentrates 
may contain residual leukocyte fragments that may 
cause the same posttransfusion complications as 
previously described for intact leukocytes. 51
Because of its efficiency in depleting leukocytes 
from blood, the freeze-thaw method has long been 
considered as the optimal method for the prepara- 
tion of leukocyte-poor blood.19'25 However, sev- 
eral logistic difficulties uch as the requirement for 
expensive facilities for the freezing and storage of 
cells, the limited availability of products on a rou- 
tine basis, and the short expiration period because 
of open-system handling have led to the displace- 
ment of this method by other approaches. 
Filtration. Filtration as a means to remove 
leukocytes from blood became routine practice af- 
ter the development of microaggregate filters. Re- 
moving aggregates from blood to prevent forma- 
tion of emboli in recipients after transfusion was 
accomplished with the use of these microaggregate 
filters. 18,53,54 Although originally not intended for 
this purpose, microaggregate filters have been re- 
ported to have an appreciable leukocyte-removal 
capacity. 24'55'56 Over the last decades, microag- 
gregate filtration has evolved into a method to pro- 
duce leukocyte-poor blood. Currently available 
special leukocyte filters do not require microaggre- 
gate formation before filtration, because their 
function is based on differences in deformability 
and adhesiveness between different cells (Table 1). 
These filters generally remove more than 95% of 
the total number of leukocytes in one unit of blood, 
whereas the red blood cell loss typically is less 
than 10% (Table 2). 
Nowadays, leukocyte filtration is the most com- 
monly used method to prepare leukocyte-poor 
blood. The procedure is simple, fast, clinically ef- 
fective, and does not require expensive quip- 
ment. 1.11.12.58 Moreover, the process does not re- 
quire open-system handling, which favors the shelf 
life of the products. Nevertheless, leukocyte filters 
can be further improved by the optimization of 
leukocyte-depletion capacity, red blood cell recov- 
ery, processing time, and cost. 
Development ofLeukocyte Filters 
Filtration as a means to remove leukocytes from 
blood was first described in 1926 by Fleming, who 
used a column filled with cotton wool to prepare 
small quantities of leukocyte-poor blood. 66 In sub- 
sequent years, a number of filters of different ma- 
terials were developed, 16"37 but it took until 1962 
before Greenwalt et al reported a filtration method 
for use in blood bank practice.6V When heparinized 
blood was filtered over columns filled with Orlon 
(Du Pont de Nemours, Geneva, Switzerland), Da- 
cron (Du Pont de Nemours), Teflon (Du Pont de 
Nemours), or nylon fibers, it was found that leu- 
kocyte removal was most effective when nylon fi- 
ber filters were used. With these filters granulo- 
cytes were completely removed, whereas most of 
the lymphocytes were recovered in the filtrate. Al- 
though leukocyte removal was only partial, the in- 
cidence of NHFFR in recipients was significantly 
reduced when granulocyte-poor blood was used for 
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Table 2. Survey of Currently Available Filters to Remove Leukocytes From Blood 
Depletion Recovery 
Trade Name Manufacturer Filter Material WBC (%) RBC (%) References 
Imugard IG500 Terumo, Tokyo, Japan Cotton wool 93-98 85-97 1, 3, 22-24, 56-59 
Cellselect* NPBI, Emmercompascum, The Netherlands Cellulose acetate fiber >99 75-88 3, 57, 60 
Erypur* Organon, Boxtel, The Netherlands Cellulose acetate fiber 96-98 90-99 1, 56, 57, 59, 61 
Miropore Miramed, Mirandole, Italy Cellulose acetate fiber 95-99 >92 3, 58 
Leukoseize Dideco, Mirandole, Italy Cellulose acetate fiber >95 >92 58 
Sepacell R500 Asahi, Tokyo, Japan Polyester fiber 95-98 8-96 3, 57, 58, 60-64 
Optima NPBI, Emmercompascum, The Netherlands Polyester fiber 95-99 86-92 58, 60, 62, 63 
RC100 Pall, Glen Cove, NY Polyester fiber 98-99 75-94 57, 60, 62, 63 
Leukostop Miramed Polyester fiber 95-98 88-92 58, 60 
Leukopakt Travenol, Thetford, UK Nylon fiber 42-54 90-99 22, 56 
Ultipor SQ40S$ Pall Polyester mesh 13-57 93-95 53-56, 65 
4C 2423r Fenwall, Glendale, CA Polyester wool -44  -66  53, 54, 56 
Note: It should be noted the data in columns headed Depletion WBC and Recovery RBC were obtained from different laboratories 
and that different filtration methodologies may have been used. For example, some investigators have filtered whole blood, 
whereas others have used red blood cell concentrates, ie, blood from which plasma and/or buffy coat was removed by centrifu- 
9ation. 
* In some countries, the Cellselect filter is marketed by Organon, The Netherlands, under the trade name Erypur. 
5" The Leukopak filter was originally designed to harvest granulocytes from heparinized blood. 22 
t The Ultipor and 4C 2423 filters were originally designed to remove microaggregates from stored blood, but are known to have 
appreciable leukocyte removal capacity, s5,56 
transfusion. 67 Filtration over nylon fibers later 
evolved into a technique to isolate lymphocytes 
from blood 68 and was also used to purify granulo- 
cytes by a technique known as filtration leukaphe- 
res i s .  69'7~ 
The leukocyte filtration technique was substan- 
tially improved in 1972 by Diepenhorst, who de- 
veloped aprototype leukocyte filter consisting of a 
column filled with tightly packed cotton wool. 71 
Using this filter, more than 95% of all leukocytes 
in whole blood could be removed, whereas red 
blood cell loss was less than 10%. Two years later, 
the first disposable leukocyte filter for routine use 
in blood banks became available. 72 A similar fil- 
ter, the Imugard IG-500 (Terumo Corp, Tokyo, 
Japan), based on the Diepenhorst prototype was 
introduced in 1978. 73 Several clinical studies have 
shown that such filters are effective in the prepa- 
ration of leukocyte-poor blood (Table 2). 
Soon after the introduction of the cotton wool 
fibers, other types consisting of cellulose acetate 
fibers were developed. The replacement of natural 
by synthetic fibers led to less pyrogenic filters 59 
and constant quality of the filter material, 94 result- 
ing in safer products. Cellulose acetate filters are 
still widely used to remove leukocytes. 
More recently, the technology to prepare leuko- 
cyte filters has advanced considerably. The obser- 
vation that leukocyte removal by filters was ac- 
complished, at least in part, by adhesion of cells to 
the filter fibers led to the preparation of filters with 
larger internal surfaces, 75 which can be achieved 
through the use of small-diameter fibers (Fig 1). A 
melt-blowing process, in which a molten polymer 
is cast into fibers by a high-velocity stream of gas 
and collected as a nonwoven web, is used to pre- 
pare webs of fibers with an average fiber diameter 
of less than 2 I, tm. 75'76 Such thin fibers have been 
reported to be more effective for leukocyte deple- 
tion as compared with fibers with a larger diame- 
ter. 77 Current leukocyte filters (Table 2) consist of 
different layers of nonwoven polyester fibers that 
can easily be processed by melt blowing. Polyester 
fiber filters have been shown to be very effective in 
the preparation of leukocyte-poor blood, as is 
shown by the removal of up to 99.9% of leuko- 
cytes. 60'61"78'79 Recently, the development of a fil- 
ter that removes 99.9999% of leukocytes was re- 
ported. 8~ 
Although most currently used leukocyte filters 
show a high efficiency, further optimization is still 
desirable. 61 Filters that can produce red blood cell 
concentrates that are completely free of leukocytes 
have not yet been developed but may be beneficial 
for the various clinical situations discussed previ- 
ously. Another characteristic tobe optimized is the 
filter capacity. Increased leukocyte removal capac- 
ity may lead to a reduced filter size and thus to a 
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Fig 1. Typical example of the 
different diameters of fibers, 
used in (A) traditional cellulose 
acetate fiber filters (Cellselect; 
NPBI) and (B) current polyester 
fiber filters (Optima; NPBI). 
higher yield of purified red blood cells, which is 
desirable for both clinical 1 and logistical pur- 
poses. 23 Filter optimization may also reduce the 
cost and length of filtration and lead to easier fil- 
tration procedures. 1 Overall, leukocyte filtration is 
still a relatively expensive method to prepare leu- 
kocyte-poor blood, as compared with other meth- 
ods such as differential centrifugation and wash- 
ing. 23 Reduction of the processing time is 
advantageous for the rapid provision of leukocyte- 
poor blood 6~ and for the application of filtration 
directly at the bedside. 79 
Thus far, the optimization of filter materials has 
been achieved largely by trial and error. The de- 
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velopment of new filters would benefit from a bet- 
ter understanding of the mechanisms causing leu- 
kocyte depletion. So far, these mechanisms have 
not been studied systematically, although it has 
been suggested by several investigators that leuko- 
cyte filtration is governed by sieving and adhe- 
sion. 21'22'6~ However, the quantitative con- 
tribution of each of these factors has never been 
rigorously investigated. 
LEUKOCYTE FILTRATION MECHANISMS 
Filtration processes are usually divided into 
three categories; urface filtration, cake filtration, 
and depth filtration. 82'83 Surface filtration is the 
process in which particles larger than a given size 
cannot pass through the filter surface, causing a 
complete separation of these particles from the sus- 
pension medium. Because the retained particles 
will rapidly clog the filter, surface filtration is only 
possible when the particle concentration is low. 
During cake filtration the filtered particles form a 
porous layer, a cake, on top of the filter. As long 
as flow through this filter cake is possible, the 
layer itself will contribute to the retention of more 
particles. For depth filtration, the retention of par- 
ticles is not restricted to the filter surface. In gen- 
eral, depth filters have an open porous structure, 
with a wide distribution of pore sizes throughout 
the filter matrix. This specific structure allows the 
retention of particles at any place inside the filter. 
The filtration of leukocytes from blood by 
means of leukocyte filters can be regarded as a 
depth filtration process. 65 Depth filters usually 
consist of a bed with tightly packed granular or 
fibrous material, s4'85 and are most frequently used 
for the purification of waste water s2,84's6'87 and 
gases. 8s Although membranes are often regarded 
as surface filters, 82's9 open cellular foams resem- 
bling membranes have rarely been used for depth 
filtration. 9~ The theory developed to explain the 
mechanism of depth filtration has been almost ex- 
clusively applied for the analysis of deep-bed sand 
filtration.83 The same theory could be used to ex- 
plain leukocyte filtration but this has never been 
reported. 
Several elementary mechanisms are known to 
play a role in the retention of particles in depth 
f i l ters. 86'87'93'94 The mechanisms that are probably 
involved in leukocyte filtration include blocking or 
Fig 2. Schematic diagrams of elementary mechanisms of 
particle retention in depth filters; (A) blocking, (B) bridging, 
(C) interception, either dead end (a), labile (b), or stable (c), 
and (D) adhesion. 
straining, bridging, interception, and adhesion 
(Fig 2). Combinations of the afore-mentioned 
mechanisms may also occur. Blocking may occur 
when the particle size is larger than the diameter of 
the pore that has to be passed. Bridging becomes 
significant at high particle concentrations 95 and oc- 
curs when two or more particles imultaneously 
flow through a relatively large pore and become 
entrapped as an aggregate. Interception is the pro- 
cess in which particles are mechanically trapped at 
filter sites other than small pores. Interception may 
be stable, labile, or occur at dead ends (Fig 2). 
Adhesion of particles to the filter material becomes 
important when the ratio of particle to pore diam- 
eter 93'94 is about 10 -4 to 10-~. When adhesion 
occurs, the action of mechanical forces such as 
gravity, hydrodynamic pressure, or fluid flow is 
not necessarily a prerequisite o retain the particle 
in the filter. Because depth filtration is generally 
concerned with the removal of particles that are 
many times smaller than the pores of the filter, the 
effects of blocking, bridging, and interception are 
often neglected because adhesion is the predomi- 
nant mechanism. 87"96 
An alternative approach to explain depth filtra- 
tion is to distinguish mechanical entrapment (siev- 
ing) from physico-chemical entrapment (adhe- 
sion). The pore size of the filter then determines if 
LEUKOCYTE REMOVAL BY FILTRATION 151 
sieving becomes important. Based on particle/filter 
dimensions, it has been assumed that sieving oc- 
curs when particles are larger than 30 ~m and that 
adhesion occurs when particles are smaller than 1 
[xm. 85'86 When the particle size is between 1 and 
30 Ixm, as occurs during leukocyte filtration, both 
processes likely occur simultaneously. 
Cell Sieving 
Because blood cells differ both in size and de- 
formability, sieving should be considered as a pos- 
sible mechanism in the filtration of leukocytes (Ta- 
ble 1). Very little is known about the role of 
sieving in cell filtration processes, although the 
literature in the field of biorheology and microvas- 
cular research provides some information about 
possible effects of porous matrices on blood cell 
separation. 
Pore size effects. The degree of deformability 
of leukocytes i approximately one thousand times 
less than red blood cells. This factor is determined 
by the resistance of a blood cell to flow through a 
small capillary, 31'97 and depends on the viscoelas- 
tic properties of the cytoplasm, the plasma mem- 
brane, the cell shape, and the cell surface area/ 
volume relationship. 32 The extent of cell 
deformability is generally reduced 98 in the pres- 
ence of Ca 2 +, and therefore dependent on the an- 
ticoagulant used. 99 
As a result of differences in deformability, leu- 
kocytes have difficulty passing pores with a diam- 
eter less than 5 lxm, whereas red blood cells wilt 
easily pass 3-txm pores 29'1~176176 (Fig 3). Thus, 
when blood cell mixtures are filtered through a 
filter with pores of 3 to 8 txm, the leukocytes will 
selectively obstruct small pores by a process 
known as pore plugging. The time-dependent i -
crease in pressure, which is required to continue 
the flow of red blood cells through the filter, has 
been mathematically described by a complex func- 
tion of several factors, such as cell deformability, 
pore size, pore size distribution, pore length, blood 
cell composition, and stirring. 1~176 Simplified 
expressions are available for filtration through Nu- 
clepore filters which have well-defined capillary 
pores, 3]'97 but the relevance of these mathematical 
calculations with respect o leukocyte filters in 
which the porous tructure is very irregular is prob- 
ably low. 
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Fig 3. Effect of filter pore size on the possibility for blood 
cetls to flow through pores IA) and hemolysis thresholds (B), 
at room temperature. Experimental data adapted from 
Lichtman zs.s~ and Blackshear. 1~176 
size of the filter, the hydrostatic pressure applied 
also determines whether cells will flow through 
pores. Hemolysis may occur when the stress on the 
red blood cell membrane reaches a critical value, 
which is defined by both the filter pore size and the 
applied pressure 1~176 (Fig 3). In some cases, ie, 
when the pores are very small and the pressure is 
low, the flow of red blood cells through the filters 
can be completely stopped. 1~176 
The effects of pore size in leukocyte filters have 
been Studied by Bruil et al 1~ Using well- 
defined model filters composed of membranes, 
they found that leukocytes were only successfully 
removed when the filter pore size approached the 
size of leukocytes ( -10  Ixm). However, because 
of clogging, blood flow through such filters rap- 
idly decreased, resulting in low filter capacity. 
With asymmetric membrane filters, in which the 
pore size decreased from about 65 to 15 Ixm in the 
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direction of blood flow, both moderate removal of 
leukocytes and maintenance of flow were ob- 
tained. The clogging phenomena were also en- 
countered by Callaerts et al, who reported similar 
observations with nonwoven fiber filters in which 
the average pore size ranged from 7.3 to 14.2 
Dxm. 1o6 
Pore-branching effects. Because of relatively 
small deformation during flow, the axial velocity 
of leukocytes in capillaries is generally lower than 
that of red blood cells. 107 For example, in a cap- 
illary with a diameter of 6.8 txm the ratio of leu- 
kocyte to red blood cell velocity is 0.88 + 0.06. 34 
This difference causes a nonhomogeneous di tri- 
bution of cells and plasma in the capillary, because 
slowly moving leukocytes will retard the move- 
ment of red blood cells. 107,1o8 At branching points 
it is likely that leukocytes will continue to move in 
those capillaries with the largest diameter, but with 
time the flow rate will decrease, with the red blood 
cells continuing to flow in the other capillaries. 
The results of theoretical simulations have con- 
firmed that blood cells can be nonuniformly dis- 
tributed over two divergent capillary branches.l~ 
This deviation from a uniform distribution of cells 
increases as the diameter of the capillaries be- 
comes smaller, lO9 The effects of capillary branch- 
ing on blood cell separation become significant 
when capillaries have a diameter of approximately 
10 I, zm 32 (Fig 4). 
Margination effects. When blood flows 
through small capillaries, the red blood cells will 
generally assume the axis of the capillary. 33,110,111 
This effect is caused by the flexible and biconcave 
shape of red blood cells or by the formation of red 
blood cell aggregates, making these cells very sus- 
ceptible to radial migration in a flowing fluid. Be- 
cause the flow rate is highest in the center of ves- 
sels, red blood cells are driven to flow in the axis 
of the capillary. As a result, leukocytes, which are 
stiff and round and therefore less susceptible to 
flow, will be pushed to the capillary wal l .  111-113 
This process, known as margination, may stimu- 
late leukocytes to adhere to the capillary wall. 
Although the effects of margination on cell ad- 
hesion increase as the diameter of the capillary 
becomes maller, u3 the adhesion of leukocytes in 
small blood vessels is generally inhibited by high 
fluid shear stresses at the capillary wall, which 
become predominant in small capillaries. ~3 In this 
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respect it should be kept in mind that products 
released by vascular cells may affect he behavior 
of blood cells, whereas synthetic materials lack 
this property. The mechanical trapping of leuko- 
cytes by interception (Fig 2) is probably promoted 
by their margination i  blood filters. 
Cell Adhesion 
Adhesion of blood cells to solid surfaces is a 
complicated process, and the underlying mecha- 
nisms are poorly understood. The cell membrane 
should be regarded as a heterogeneous surface, 
composed of a pbospholipid matrix that contain 
clusters of glycoproteins.114 These glycoproteins, 
which are often receptors, regulate cell behavior, 
including the adhesion of the cell to a given sub- 
strate. ] 15-117 Specific leukocyte adhesion receptors 
such as LFA-1, Mac-1 and p150,95, l]s-12~ which 
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are related to a larger family of Arg-Gly-Asp 
(RGD) receptors, lz~ are often located on the 
cell membrane. Although several investigators 
have explored receptor-mediated cell adhesion 
during cell affinity chromatography, 115, ia7.123,124 
the relevance of these studies to leukocyte filtra- 
tion is not clear. 
The nonspecific adhesion of leukocytes to sur- 
faces has been extensively described in the litera- 
ture. A survey of the best-recognized factors 
known to be important follows. 
Surface chemistry. Several investigators have 
tried to relate the extent of cell adhesion to the 
chemical composition of the substrate surface, but 
very few specific studies using leukocytes are 
available. Curtis et al have studied the adhesion of 
leukocytes and baby hamster kidney (BHK) cells 
to modified polystyrene surfaces. They found that 
adhesion of both cell types was promoted by hy- 
droxyl groups, and inhibited slightly by carboxylic 
acid groups. 125-127 Bruil et al reported that the ad- 
hesion of granulocytes and lymphocytes to poly- 
urethane surfaces increased substantially after 
modification with amine groups but only slightly 
after modification with carboxylic acid groups. 128,129 
Other investigators have studied distinct cell 
types with respect o adhesion. When reviewing 
such data, it should be kept in mind that the adhe- 
sion of different cells may differ greatly. Thus, 
surfaces bearing hydroxyl groups, 125-127,130,131 
carbonyl groups, 132 and amine groups 133'134 have 
been reported to enhance cell adhesion, whereas 
sulphonate groups 125'134-136 are known to inhibit 
adhesion. The effect of carboxylic acid groups is 
controversial. Ramsey et al reported increased ad- 
hesiveness of monkey kidney cells to polystyrene 
plates after the introduction of carboxylic acid 
groups by oxygen gas plasma treatment. 137 Similar 
results were found by Klemperer and Knox, who 
reported rapid attachment of BHK cells and rat 
liver cells on chromic acid-treated polystyrene 
dishes, which was attributed to the introduction of 
carhoxylic acid groups. 135 On the other hand, 
other investigators found that the adhesion of BHK 
cells on carboxylized polystyrene surfaces was in- 
hibited only slightly as compared with carboxyl- 
ized polystyrene surfaces on which these cells 
were blocked by acetylation 125 or methylation. 127 
It should be emphasized that the introduction of 
specific chemical groups at the substrate surface 
not only changes the surface chemistry but may 
also alter the physical surface properties uch as 
charge, wettability, and microstructure. Moreover, 
the physico-chemical properties of the surface may 
readily be altered by the adsorption of proteins 
from the cell suspension medium. As each of these 
factors has inherent effects on cell adhesion, as 
will be discussed subsequently, it is difficult to 
study the effect of a single parameter.a38 This may 
explain why the results of adhesion studies re- 
ported by different investigators do not always 
agree. 
The effect of various urface chemical groups on 
cell adhesion in leukocyte filters have been studied 
by Bruil et al. 139 With the use of a surface modi- 
fication technique, they were able to prepare 
model filters that were structurally identical but 
which differed with respect to the presence of sur- 
face amine groups. When filtration was performed 
using purified leukocytes in the absence of red 
blood cells, platelets, and blood plasma, the num- 
ber of cells removed by amine group-modified fil- 
ters was significantly greater than unmodified fil- 
ters. However, no significant differences between 
the filters were found when the filtration was per- 
formed using whole blood. It was postulated that 
the physico-chemical properties of the filter sur- 
face were overshadowed by other characteristics 
affecting leukocyte behavior during filtration. 
Surface charge. Like most mammalian cells, 
leukocytes have a net negative surface charge 14~ 
caused by the presence of anionic groups such as 
phosphate, sialic acid, and carboxylic acid groups 
on the cell membrane. 142'143 Electrostatic forces, 
either repulsion or attraction, may consequently 
influence cell adhesion. 141,144 It has been reported 
that whereas negatively charged substrates reduce 
cell adhesion,t34'145'146 positively charged sub- 
strates promote it. 134'145-148 These findings are in 
general agreement with the previously discussed 
effects of ionizable functional groups, which may 
easily affect he charge of solid surfaces. 
The Derjaguin, Landau, Verwey, and Overbeek 
theory, which describes the free energy of a col- 
loidal particle as a function of the inter-particle 
distance, has often been used to predict he rate of 
cell adhesion to surfaces with different surface 
charges. 145'149'150 This theory defines the deposi- 
tion rate of cells to a solid surface by the presence 
and height of an energy barrier, which depends on 
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electrostatic interactions and London-van der 
Waals interactions between the surface and the 
cells. It follows from this theory that the chance for 
cells to adhere is smaller when a surface is more 
negatively charged. 
However, leukocyte adhesion is not necessarily 
inhibited by negatively charged surfaces. Leuko- 
cytes often form pseudopods,151 which easily pen- 
etrate the electrical double layer of the negative 
substrate, thus facilitating close contact and the 
molecular interactions between the cells and the 
surface. 141 Groth et al have reported that the num- 
ber of leukocytes adhering to polyurethane sur- 
faces increases when the surface becomes more 
negative. 152 
Surface wettability. There exists a widely ac- 
cepted concept hat wettable, or hydrophilic, sur- 
faces promote the adhesion of leukocytes as com- 
pared with nonwettable,  or hydrophobic ,  
surfaces. 4~ However, contradictory re- 
suits were reported by Lim and Cooper, who used 
a series of polyurethane surfaces differing in wet- 
tability and found that most granulocytes adhered 
to the most hydrophobic surface. 154 Van Kampen 
et al found large numbers of adherent leukocytes in 
dogs on implants consisting of both hydrophobic 
and hydrophilic polyaminoacids.155 Some investi- 
gators have used the hydrophobic interactions of 
blood cells with hydrophobic substrates toseparate 
blood cells by affinity chromatography. 156'157 
To explain the increase of leukocyte adhesion to 
surfaces with increased wettability, Neumann et al 
used a thermodynamic model in which the change 
in free energy resulting from adhesion was related 
to the surface free energy of the solid sur- 
face, 158'159 which in turn is related to the surface 
wettability.160 This model has also been used to 
relate the adhesion of platelets 158' 161 and red blood 
cells 159'162 to the wettability of the solid surface 
and to determine if the efficiency of microaggre- 
gate filters depends on the wettability of the filter 
material. 163 In the latter study it was shown that 
the number of leukocytes and platelets retained by 
these filters was proportional to the surface free 
energy of the filter material. The same theory 
could probably be used to explain the different 
efficiencies of the different leukocyte filters. How- 
ever, it should be emphasized that the model does 
not account for effects of surface charge on cell 
adhesion. 
Surface microstructure. Synthetic substrates 
are generally nonhomogeneous and sometimes 
show a microstructure, ie, the surface consists of 
small microdomains differing in chemical compo- 
sition. Because the membrane structure of most 
cells may easily rearrange during adhesion, 114 it is 
likely that cell adhesion is influenced by the mi- 
crostructure of the substrate surface, ie, a structure 
consisting of small microdomains differing in 
chemical composition. Kataoka et al have studied 
the adhesion of blood cells onto materials with 
various microphase-separated structures, com- 
posed of neutral-charged, 164,165 hydrophobic- 
hydrophilic, 166'167 or crystalline-amorphous 168'169 
domains. The degree of cell adhesion to these ma- 
terials, which is influenced by the size and type of 
the microdomain at the solid surface, was in gen- 
eral low compared with surfaces without such a 
microstructure. Moreover, it has been reported by 
Okano et al that different plasma proteins selec- 
tively adsorb to either hydrophilic or hydrophobic 
microdomains, 17~ thereby forming protein-coated 
microstructures, with similar effects on cell adhe- 
sion as described previously for uncoated micro- 
structures. 
Several frequently used block copolymers uch 
as polyurethanes 171'172 are known to have a mi- 
crophase-separated surface structure. Cell adhe- 
sion to such materials may be substantially reduced 
compared with materials with a homogeneous sur- 
face structure. 
Surface morphology. Certain surface morpho- 
logical features uch as porosity, curvature, and 
texture are known to influence cell adhesion to 
extracellular substrates. 4~ Furthermore, the adhe- 
sion of platelets 173 and red blood cells 174 to porous 
surfaces is often diminished during perfusion of 
the suspending fluid through the pores of the sur- 
face. However, fibroblasts adhere more firmly to 
porous surfaces compared with smooth sur- 
faces. 175 Surface roughness is also known to in- 
fluence cell adhesion, as was shown by the pattern 
of erythrocyte adhesion to a number of sub- 
strates.176 Macrophages and platelets adhere pref- 
erentially to rough surfaces compared with smooth 
surfaces under conditions of flow. 177'178 Guidoin 
et al observed larger numbers of adherent leuko- 
cytes and platelet aggregates in blood filters with 
an irregular and imperfect surface texture com- 
pared with filters having a smooth surface. 65 
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The effect of surface roughness on cell adhesion 
was attributed to the presence of air nuclei at rough 
surfaces, which may enhance cell adhesion. 179 Air 
nuclei at rough surfaces, formed particularly in hy- 
drophobic substrates, are known to activate the 
complement system, 180 which in turn may mediate 
the adhesion of leukocytes to artificial surfaces. 
Complement activation. The human comple- 
ment system is a complex group of at least 25 
plasma proteins that, after activation, interact with 
each other in a sequential manner to produce bio- 
logical effector molecules. 181,182 One of the phys- 
iological functions of the complement system is 
the regulation of the immunological response to 
bacterial or viral infections via the so-called clas- 
sical pathway. Complement activation is also 
known to be involved in the adhesion of leukocytes 
to artificial surfaces. 183-185 Activation of the 
Ca 2+- and Mg2+-dependent al ernative pathway 
generates C3a and C5a fragments, which are 
known to mediate the adhesion and aggregation of
leukocytes. ~ 85- lSV 
The extent of complement activation depends on 
the physico-chemical properties of the artificial 
surface. ~88'189 Protein preadsorption, IgG in par- 
ticular, 19~ and the presence of air nuclei at the 
material surface ~8~ alter the effect of complement. 
The complement activation potential of some com- 
monly used polymers is shown in Table 3. Nega- 
tively charged surfaces are known to have a rela- 
tively low propensity to activate complement, 
probably because of adsorption (ie, inactivation) of 
the cationic C5a. 191 Nucleophilic groups such as 
amine 19~ and hydroxyl 186'193 have been re- 
ported to activate the complement system. In this 
respect, it should be noted that functional groups 
of denaturated plasma proteins preadsorbed onto 
the material surface rather than the material itself 
may cause complement activation. 188,189 
Protein adsorption. One of the first events to 
occur when materials are exposed to blood, even 
before cells can adhere, is the adsorption of plasma 
proteins to the surface. During this process, there 
is competition between the various proteins present 
in the plasma. The initially adsorbed small pro- 
teins, which have a high diffusion coefficient and 
occur in a high concentration, are sequentially dis- 
placed by larger proteins, which have a higher af- 
finity toward the surface but are present in a lower 
concentration and have a lower diffusion coeffi- 
cient. Gradual displacement of adsorbed proteins, 
known as the Vroman effect, occurs on hydro- 
philic surfaces in the following sequence; albumin, 
IgG, fibrinogen, fibronectin, high molecular 
Table 3. Survey of Polymer Material 9  for Complement Activation and Leukocyte Adhesion Potential 
Complement Leukocyte 
Materia(s)/Common Name Activation* Adhesiont References 
Polyacrylonitrile 9 ee 9 194-196 
Polycarbonate 9 9 194, 195, 197 
Polyethylene 9 ee 158, 159, 188, 198-200 
Polypropylene 9 ee 189, 195, 201 
Polytetrafluoroethylene/Teflon 9 9 158, 159, 180, 195, 202 
Polystyrene 9 9 126, 158, 159, 189, 195, 203 
Polysulfone 9 9 194, 195, 201 
Polyvinylchloride 9 9 189, 195, 200 
Cellulose acetate ee eee 60, 194, 195, 198 
Polydimethylsiloxane/Silicon rubber ee ee 158, 180, 188, 199, 201 
Poly(ethylene terephthalate)/Dacron ee eee 60, 158, 195, 202 
Poly(methyl methacrylate) ee eee 185, 189, 194, 195, 198 
Polyurethanes ee ee 129, 153, 188, 189, 195, 204 
Cellulose/Cellophane eee eee 180, 194, 195, 201,204 
Polyaramids/Nylons eee eee 158, 185, 195 
Poly(hydroxyethylene methacrylate) eee 9 186, 203 
Polyvinylalcohol eee 9 198, 204, 206 
* Relative potential to activate complement (more dots, more activation), arbitrarily classified according to hemolytic activity or 
C3a/C6a generation. Results taken from various studies by different investigators. 
t Relative susceptibility to leukocyte adhesion (more dots, more adhesion), arbitrarily classified after comparison of results from 
various studies by different investigators. 
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weight kininogen, and factor XlI. 206-209 The rate 
and amount of protein adsorption are dependent on 
the physico-chemical properties of the material 
surface. 2~176 In general, proteins adsorb stronger 
and to a larger extent o hydrophobic surfaces than 
to hydrophilic surfaces. 211-213 
Leukocyte adhesion to surfaces is largely influ- 
enced by preadsorbed proteins. It is well known 
that albumin has an inhibitory effect on the adhe- 
sion of leukocytes to solid surfaces, 40'126'158'214'215 
whereas globulins enhance the adhesion of leuko- 
cytes. 2~ Fibronectin (Fn) 216'217 acts as a 
bridging molecule between the cells and the sub- 
strate in many cell-adhesion processes. 218'219 Al- 
though the concentration f Fn in plasma is low, it 
has been reported that Fn is a normal constituent of
the leukocyte membrane, which may be secreted 
on activation of the celts. 22~ Several investigators 
have used the cell adhesive properties of fibronec- 
tin, 221 and the RGD peptide sequence, 122'2~ 
which is regarded as the active site of fibronec- 
tin, 222'223 to enhance cell adhesion to artificial sur- 
faces. 
The plasma concentration level required to 
achieve optimal protein adsorption for optimal leu- 
kocyte adhesion during filtration is not known. 
The results of experiments with leukocytes re- 
ported by Bruil et al favor the use of filtration 
conditions in which the concentration f plasma is 
reduced, zz4 However, Shimizu et al found that the 
leukocyte depletion efficiency of polyester fiber 
filters did not alter when the cells were stored is a 
plasma-poor medium. 225 
Platelet adhesion. There is evidence that ad- 
herent platelets promote subsequent adhesion of 
leukocytes. It was reported in 1961 by Garvin that 
the extent of adhesion of polymorphonuclear leu- 
kocytes to siliconized glass wool was dependent on 
prior adherence of platelets. 37 Similar effects were 
reported by other investigators. 226'z27 Bruil et al 
have studied the adhesion of granulocytes tomod- 
ified polyurethane surfaces under flow conditions 
and found that the presence of platelets in the cell 
suspension medium led to a significant increase in 
the number of adherent cells. 224 Steneker et al 
showed that the break-through point during filtra- 
tion of leukocytes was achieved earlier in the ab- 
sence of platelets in the cell suspension than in the 
presence of platelets. 228 It has also been reported 
that activated platelets can release adhesive pro- 
teins such as fibrinogen, fibronectin, and von 
Willebrand factor, which may promote leukocyte 
adhesion. 227 Alternatively, activated platelets may 
express a receptor generally known as PADGEM 
(platelet activation-dependent granule-external 
membrane protein; GMP-140), to which leuko- 
cytes may adhere. 229-231 
The physiological aspects of platelet-leukocyte 
interactions have been well documented, ~32 but the 
significance of these interactions with respect o 
leukocyte filtrations has received less attention. 
Swank studied the attachment of cell aggregates to
glass wool filters by a microscopic technique and 
concluded that adhesion of platelets to leukocytes 
is essential for effective filtration. 16 Steneker et al 
have recently performed an electron microscopic 
examination of leukocyte depletion in leukocyte 
filters in which the adhesion of granulocytes to 
platelets was observed. 233 Similar observations 
were also reported by Bruil et al. 104 It thus seems 
that the adhesion of granulocytes toplatelets is an 
important factor for the depletion of leukocytes by 
leukodepletion filters. 
Composition of blood. The composition of the 
blood may influence leukocyte adhesion in many 
aspects. Because ach of the leukocyte subpopu- 
lations has a different tendency to adhere to artifi- 
cial surfaces (Table 1), the overall degree of leu- 
kocyte adhesion depends on the concentration a d 
composition of the leukocyte population. The 
number of platelets i  important with respect to the 
effects already discussed. Red blood cells may in- 
fluence leukocyte adhesion under conditions of 
flow, because these cells are known to promote the 
migration of leukocytes to the substrate surface. 
Several investigators have reported that leuko- 
cyte adhesion is reduced in the presence of 
plasma. 40'201'215'224 Forrester et al found that leu- 
kocyte adhesion to glass slides was inhibited when 
the cells were suspended in autologous plasma 215 
probably because of the adsorption of albumin to 
the substrate. Bruil et al found that the number of 
granulocytes that adhered to modified polyure- 
thane films from saline was approximately four 
times high compared with the number that adhered 
from plasma in saline. 224 However, some investi- 
gators have reported that plasma does not inhibit 
but sometimes even promotes leukocyte adhesion 
to glass surfaces. 38'234 
Divalent ions, Ca 2 + and Mg ~ + in particular, are 
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generally known to promote leukocyte adhe- 
sion. 37'4~ Hoover et a1235 re- 
ported that the extent of leukocyte adhesion to en- 
dothelium is maximal in the presence of Mn 2+, 
followed by Zn 2+ > Ni 2+ > Mg 2+ > Ba 2+ > 
Ca 2+. With respect to leukocyte filtration, it 
should be noted that not only the adhesiveness but 
also the deformability of leukocytes i  affected by 
divalent ions. 98'99 
The effect of anticoagulants on leukocyte adhe- 
sion is primarily caused by the lowering of the 
concentration of divalent ions, 37 except for hepa- 
rin, which does not bind Ca 2+ and Mg 2+ . In ci- 
trate-anticoagulated blood the concentration of 
Ca 2 + and Mg 2+ , although low, is still enough to 
permit leukocyte adhesion. 37 When ethylene- 
diaminetetraacetic acid (EDTA) or oxalate is used 
as anticoagulant, he concentration of free Ca 2+ 
and Mg 2+ is negligible and leukocyte adhesion is 
inhibited.37, 39,236 
Mathematical Models 
Mathematical models to describe the leukocyte 
filtration process, based on current knowledge of 
filtration mechanisms, may be helpful to explain 
results obtained with leukocyte filtration and to 
optimize filters and filtration procedures. Only a 
few attempts to describe mathematically the leu- 
kocyte filtration process are known. Diepenhorst 
evaluated a mathematical model, originally de- 
rived to explain the removal of ferrous hydroxide 
particles from ground water through sand beds, to 
describe the filtration of leukocytes through cotton 
wool filters but did not succeed in explaining his 
experimental results. 237 More recently, Prins de- 
veloped a computer model to explain the depletion 
of leukocytes in filters composed of filter segments 
with different leukocyte-trapping efficiencies. 238 
However, a shortcoming of the model was that its 
parameters were based on empirically derived 
probability factors, and therefore the theoretical 
value of the model is minimal. Moreover, the sta- 
tistical basis of the model reduces its adaptivity in 
process engineering and product design. 
More sophisticated filtration models have been 
derived to optimize applications in the field of 
chemical engineering. 239-z42 Bruil et a1243 have 
adapted the basic theory from these studies to de- 
scribe the leukocyte filtration process. With the 
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use of this theory it was possible to compare quan- 
titatively the filtration characteristics of different 
filter materials and to calcuiate the dimensions of a 
leukocyte filter composed of a specific material. 
The model is based on the general hypothesis of 
depth filtration, which states that the particle con- 
centration decreases per unit of filter length (Sc/Oh) 
and is proportional to the concentration of the par- 
ticles in suspension (C)83'239'244: 
c]c 
Oh Xc (1) 
The filtration coefficient h is a measure of the ef- 
ficiency of the filter and was first introduced by 
Iwasaki 245 in 1937. The filtration coefficient may 
be regarded as the particle capture probability, ie, 
the fraction of particles that is captured per unit of 
filter length. During filtration, h changes as a func- 
tion of time, because the amount of material al- 
ready deposited in the filter, or, influences the fil- 
tration of the other particles present. It is assumed 
that a limited number of retention sites (O'max) in 
the filter is accessible for the capture of particles. 
Therefore, the filter efficiency decreases on occu- 
pation of these retention sites during filtration. 
Hence, a linear decrease of h with ~r is often as- 
sumed 9~ 
(~ X = ho 1 - (2) 
O'ma x
In equation (2) h o is the filtration coefficient of the 
noncontaminated filter. As the value of h o depends 
purely on the properties of the filter material, h o 
can be described as function of the filter proper- 
ties. Some investigators have postulated that h o is 
proportional to the specific surface area (S) of the 
filter when adhesion is the predominant mecha- 
nism for particle depletion. 244'246 Assuming that S 
is inversely proportional to the filter pore size d, 104 
it follows that: 
1 
Xo - -; (3) a 
The h o values of model leukocyte filters, com- 
posed of membranes with variable average poor 
sizes, were found to agree reasonably well with 
this relation. ~43 
During leukocyte filtration the filter efficiency 
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may increase on clogging of the filter. Deposited 
platelets may enhance the retention of leukocytes 
from the blood cell suspension. 224'226-228 More- 
over, material deposited in the filter may reduce 
the apparent pore size in the filter, thus improving 
the filter efficiency. 104-106 Some investigators have 
proposed a liner expression for h as a function of 
~r, in which a factor ~ accounts for the positive 
effect of particle deposition in the filter on filter 
efficiency87,245: 
k = ko 1 + ~ (4) 
Several other elations between h and ~r have been 
reported in the literature. 84,86,244 It was postulated 
by Bruil et al that the filtration coefficient in leu- 
kocyte filters can be expressed as a linear combi- 
nation of Equations (2) and (4)243: 
h=ko 1 - 1 +~ (5) O'ma x 
This expression i cludes both the effects of filter 
properties (first term; ko), filter saturation (second 
term) and cell-cell interaction in the filter (third 
term). In this respect, the constant factor ~ can be 
defined as a cell-cell interaction parameter, which 
accounts for the positive effects of deposited cells 
on the retention of other cells. 
The amount of material deposited in the filter as 
a function of time (t) can be calculated from the 
mass balance for particles in a filter element with 
thickness Oh, which can be approximated by86: 
&r Oc 
--Ot + w ~ = 0 (6) 
Here, the fluid flow rate through the filter, w, is 
expressed in unit distance per unit time. The vol- 
ume flow rate can eventually be calculated by mul- 
tiplication of w with the planar filter surface area 
A, Hence, the leukocyte filtration process can be 
mathematically described by a differential system 
of the three Equations (1), (5) and (6), However, 
this is not an easy task. Only few cases of the 
differential system can be solved analytically. 
When ~ = 0, ie, when cell-cell interaction is 
not considered to be important in leukocyte filtra- 
tion, equation (5) simplifies to equation (2), and an 
analytical expression for the time-dependent 
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purity of the filtered product (C/Co) can be ob- 
tained86,94,243: 
c 1 
C o 1 + (exp(koh) - 1)exp(- hoWCot/(Ymax) 
(7) 
Another simplification can be made when ~ = 1. 
In this case, the analytical solution of the differ- 
ential equation becomesSr'243: 
C 
Co 
1 + exp(2koWCot/Crmax)~ 
exp(2koWCotRrma~) - 1/ 
~/l "4- \ \ex -~(~ ~ T / ( (  l -]  exp(2)koWCo//O'max)~2_ l  exp(2}koh ) 
(8) 
In the general case, in which the value of ~ is 
variable, the differential system cannot be solved 
analytically. However, a numerical solution has 
been obtained and applied to explain the effects of 
cell-cell interaction in leukocyte filtration. 243 If 
followed from this theory that the filtration break- 
through point, ie, the filtered volume after which 
an increase of the leukocyte content in the filtrate 
can be measured, is shifted toward higher volumes 
when the value of ~ is increased. 
Filtration characteristics. To describe the re- 
sults of filtration experiments by means of the gen- 
eral mathematical formulation for the filtration 
process, 243 at least three filtration parameters, ~, 
cr . . . .  and ho, should be solved independently. Be- 
cause theoretical relations for these parameters 
with the properties of the filter are not yet well 
developed, this can only be achieved by trial and 
error. However, the problem is simplified when 
the effects of cell-cell interaction in the filter are 
negligible compared with the leukocyte retention 
by the filter material itself. In this case, when ~ 
0, the filtration process is described by Equation 
(7), and the parameters O'ma x and ho can be deter- 
mined from the results of filtration experiments 
according to a method described by Heertjes and 
Zuideveld. 94 Leukocyte filtration data reported for 
different types of leukocyte filters 59'71 fit well with 
this theory (Fig 5). When the filtration parameters 
c o, h, A, and w are accurately known, the values of 
O'ma x and k o can be determined precisely and a 
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quantitative comparison of the filtration character- 
istics of different filter types is possible. 
Filter design. Another application of the 
model is to calculate the optimal dimensions of a 
leukocyte filter composed of a specific uniform 
material. For exp (hoh*) >> 1, the nominal filter 
thickness h* required to prepare a leukocyte-poor 
suspension with volume V* and a permissible l u- 
kocyte concentration c*, can be derived from 
Equation (7), 243 resulting in: 
1(co) co , 
h*=~oln  ~ +A--~m~ (9) 
Thus, when the filter parameters ho and (rma xas 
well as the leukocyte concentration c o in the sus- 
pension applied to the filter are known, the dimen- 
sions of the filter, A and h, can be optimized by 
using Equation (9). The values of ho and ~max can 
be determined by curve fitting to obtain the filtra- 
tion characteristics of different filters (Fig 5). 
CONCLUSIONS 
The evolution of leukocyte filters to prepare leu- 
kocyte-depleted red blood cell products has been 
reviewed. Currently available leukocyte filters re- 
move more than 99% of the leukocytes from whole 
blood, whereas red blood cell loss is only small. 
Although current filter performances are accept- 
able, optimization is still desirable. However, fur- 
ther improvement of leukocyte filters has been 
hampered by a lack of knowledge about he mech- 
anisms causing the depletion of leukocytes by the 
filters. 
According to the literature, many factors, many 
of which are interrelated, may be involved in the 
function of the leukocyte filters. Although most of 
these factors have been intensively studied, very 
little is known about heir relevance in the leuko- 
cyte filtration processes. Considering the complex- 
ity of the structure of current leukocyte filters and 
the composition of the blood to be filtered, it 
seems that the leukocyte filtration process can be 
defined by a complex interaction of the above 
mentioned factors, instead of by one single factor, 
as was originally suggested by several investiga- 
tors. 19'21'25'64'81'106 Although many details about 
the leukocyte filtration mechanisms are still to be 
elucidated, the filtration process can be described 
by a mathematical model. The use of this model 
may be helpful to design novel leukocyte filters. 
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Fig 5. Theoretical fit of a leukocyte filtration curve ob- 
tained by filtration of a blood cell suspension through an ex- 
perimental cotton wood filter (A), and Imugard 1(3500 filter 
(B), and an Erypur filter (C). Experimental data from Diepen- 
horst at el. 7~ (A) and Reesink et al. s9 (B and C). Fixed param- 
eters were set at ~ = 0, h = 25 cm, A = 25 cm 2, w = 0.03 om 
x s -1, and r = 5 x 106 leukocytes x cm -3 (A) or 2.1 x 10 e 
leukocytes x cm -3 (B and C). 
tration mechanisms is important in many respects. 
First, knowledge of the mechanisms causing the 
depletion of leukocytes by leukocyte filters is es- 
sential for further development and optimization of
filter materials. Second, understanding the rela- 
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t ions between fi lter eff ic iency and b lood cell func- 
t ional ity supports the standardizat ion of protocols 
for b lood col lect ion, b lood storage, and compo-  
nent  preparat ion.  Third,  awareness of  the critical 
steps dur ing the leukocyte f i l tration process may 
st imulate b lood bankers to respect and obey the 
direct ions for leukocyte f i l trat ion procedures g iven 
by fi lter manufacturers.  This may eventual ly  lead 
to a safer and more eff ic ient preparat ion of  leuko- 
cyte-depleted blood products.  
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